NCT06789432View on ClinicalTrials.gov

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hyperlipidemia (E.G., Hypercholesterolemia)
Interventions
DRUG

Atorvastatin 10 mg and ezetimibe 10 mg

Atorvastatin/Ezetimibe 10/10mg once daily

DRUG

Atorvastatin 20 mg

Atorvastatin (20 mg) Monotherapy once daily

Trial Locations (1)

Unknown

RECRUITING

Popular Medical College & Hospital, Dhaka

All Listed Sponsors
lead

Dr. Md. Alimur Reza

INDUSTRY

NCT06789432 - Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population | Biotech Hunter | Biotech Hunter